Niacin and Niacinamide Market Size, Share, Growth, and Industry Analysis, By Type (Powder Niacin and Niacinamide,Granular Niacin and Niacinamide,Liquid Niacin and Niacinamide), By Application (Human Nutrition,Pharmaceuticals,Animal Nutrition,Cosmeceuticals,Others), Regional Insights and Forecast to 2035

Niacin and Niacinamide Market Overview

The global Niacin and Niacinamide Market size is projected to grow from USD 1933.65 million in 2026 to USD 2000.75 million in 2027, reaching USD 2627.51 million by 2035, expanding at a CAGR of 3.47% during the forecast period.

The Niacin and Niacinamide market is driven by extensive use in pharmaceuticals, animal feed, human nutrition, and cosmeceuticals. Global consumption volumes exceeded 400 kilotons in 2024, supported by over 60% adoption in fortified foods and supplements. Industrial manufacturing hubs in Asia and North America account for over 70% of total supply, with increasing utilization in high-performance health products, skin formulations, and metabolic supplements. Functional versatility, including cholesterol management and skin barrier restoration, has significantly boosted demand across medical and wellness sectors worldwide.

The United States accounts for over 22% of global Niacin and Niacinamide demand, with annual consumption exceeding 88 kilotons in 2024. Strong penetration in the pharmaceutical industry, representing 45% of domestic usage, is supported by its inclusion in over 500 FDA-approved formulations. Dietary supplements enriched with Vitamin B3 compounds dominate over 35% of retail nutraceutical shelves, while cosmeceutical applications contribute 18% of U.S. market demand, driven by the growing skincare and wellness industry.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 58% demand growth linked to pharmaceutical-grade niacin usage in metabolic and cardiovascular applications.
• Major Market Restraint: 41% raw material cost volatility due to fluctuating petroleum derivative prices impacting production.
• Emerging Trends: 64% increase in cosmeceutical formulations featuring niacinamide for anti-aging and skin barrier health.
• Regional Leadership: 38% of production concentrated in Asia-Pacific, primarily China and India.
• Competitive Landscape: 52% market share controlled by top five manufacturers globally.
• Market Segmentation: 48% volume attributed to human nutrition applications.
• Recent Development: 27% increase in capacity expansions by key producers between 2022–2024.

Niacin and Niacinamide Market Latest Trends

The Niacin and Niacinamide market is experiencing diversification in end-use applications, particularly in dermatological skincare and anti-inflammatory solutions. Over 64% of newly launched skincare products in 2023 incorporated niacinamide as a primary active ingredient. The pharmaceutical sector is witnessing expanded clinical trials for niacin in neurological health, with over 40 active studies globally. Functional beverages and fortified foods now account for 25% of incremental demand, reflecting consumer trends toward preventive health solutions. Additionally, sustainability initiatives are influencing production methods, with over 30% of manufacturers adopting bio-based synthesis routes to reduce chemical waste.

Niacin and Niacinamide Market Dynamics

DRIVER

"Rising demand for pharmaceuticals."

Pharmaceutical-grade niacin and niacinamide are increasingly vital in cardiovascular disease prevention, lipid regulation, and metabolic health. Over 58% of production in 2024 was consumed by the pharmaceutical sector, backed by expanding clinical usage and WHO recommendations for vitamin B3 inclusion in essential medicines.

RESTRAINT

"Volatile raw material prices."

Around 41% of production cost fluctuations are attributed to petroleum derivative price swings, impacting synthetic niacinamide production. Supply chain disruptions in China, accounting for 32% of global capacity, have further increased price instability in recent years.

OPPORTUNITY

"Growth in cosmeceutical applications."

Niacinamide is now present in over 64% of newly launched cosmeceutical formulations, with the skincare sector projected to consume an additional 35 kilotons annually by 2030. Its role in improving skin elasticity and reducing pigmentation drives premium product adoption.

CHALLENGE

"Environmental compliance costs."

Over 28% of production facilities face rising compliance costs due to stricter environmental emission regulations. This has led to capital investments in advanced waste treatment and green synthesis, increasing overall operating expenses.

Niacin and Niacinamide Market Segmentation

The market is segmented by type and application, with human nutrition and pharmaceuticals dominating demand. Product format diversity supports different delivery mechanisms, from powders in food fortification to liquid forms in cosmeceutical serums.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Powder Niacin and Niacinamide: Powder form accounts for over 54% of global production, widely used in animal feed, fortified foods, and dietary supplements. Its long shelf life and ease of formulation make it the preferred format in over 70% of bulk purchases.

Powder Niacin and Niacinamide is valued at USD 1,045.61 million in 2025, representing 55.9% of the global market, and is projected to reach USD 1,444.54 million by 2034 at a CAGR of 3.64%, driven by its dominant use in food fortification and supplements.

Top 5 Major Dominant Countries in the Powder Niacin and Niacinamide Segment

• United States: USD 341.05 million in 2025, 32.6% share, projected to reach USD 471.56 million by 2034 at a CAGR of 3.65%, fueled by demand in dietary supplements and fortified cereals.
• China: USD 287.54 million in 2025, 27.5% share, expected to reach USD 397.34 million by 2034 at a CAGR of 3.63%, led by large-scale food and beverage manufacturing.
• Germany: USD 125.47 million in 2025, 12.0% share, forecasted to hit USD 173.14 million by 2034 at a CAGR of 3.62%, supported by cosmetics and pharmaceutical applications.
• India: USD 113.99 million in 2025, 10.9% share, projected to reach USD 157.14 million by 2034 at a CAGR of 3.64%, driven by government food fortification initiatives.
• Japan: USD 93.56 million in 2025, 8.9% share, expected to reach USD 128.64 million by 2034 at a CAGR of 3.63%, backed by functional foods and skincare sectors.

Granular Niacin and Niacinamide: Representing 28% of market volume, granular formats are essential for controlled-release formulations in pharmaceutical and nutritional applications, with 60% usage in slow-digest supplement manufacturing.

Granular Niacin and Niacinamide is valued at USD 523.26 million in 2025, capturing 28.0% of the market, projected to reach USD 707.12 million by 2034 at a CAGR of 3.46%, mainly driven by animal feed and controlled-release pharmaceuticals.

Top 5 Major Dominant Countries in the Granular Niacin and Niacinamide Segment

• United States: USD 159.82 million in 2025, 30.5% share, projected to reach USD 215.95 million by 2034 at a CAGR of 3.47%, supported by livestock productivity programs.
• China: USD 146.51 million in 2025, 28.0% share, forecasted to hit USD 198.04 million by 2034 at a CAGR of 3.45%, led by poultry and swine feed industries.
• Brazil: USD 69.50 million in 2025, 13.3% share, expected to reach USD 93.93 million by 2034 at a CAGR of 3.46%, fueled by growing meat export demand.
• Germany: USD 65.89 million in 2025, 12.6% share, projected to hit USD 89.14 million by 2034 at a CAGR of 3.45%, with strong usage in feed-grade vitamins.
• India: USD 52.14 million in 2025, 10.0% share, expected to reach USD 70.06 million by 2034 at a CAGR of 3.46%, driven by intensive poultry farming.

Liquid Niacin and Niacinamide: Holding 18% of the market, liquid forms are used in injectable pharmaceutical solutions and cosmetic serums, with 45% demand coming from the personal care sector.

Liquid Niacin and Niacinamide is valued at USD 300.02 million in 2025, holding 16.1% of the market, and is projected to reach USD 387.73 million by 2034 at a CAGR of 3.28%, primarily used in injectables, beverages, and cosmetic formulations.

Top 5 Major Dominant Countries in the Liquid Niacin and Niacinamide Segment

• United States: USD 96.15 million in 2025, 32.0% share, projected to reach USD 124.48 million by 2034 at a CAGR of 3.29%, driven by nutraceutical beverages.
• China: USD 81.01 million in 2025, 27.0% share, expected to hit USD 104.66 million by 2034 at a CAGR of 3.27%, with expanding sports drinks sector.
• Japan: USD 42.00 million in 2025, 14.0% share, projected to reach USD 54.27 million by 2034 at a CAGR of 3.28%, led by cosmeceutical liquids.
• Germany: USD 39.00 million in 2025, 13.0% share, forecasted to hit USD 50.36 million by 2034 at a CAGR of 3.28%, with adoption in premium skincare.
• India: USD 31.86 million in 2025, 10.6% share, projected to reach USD 41.29 million by 2034 at a CAGR of 3.28%, with fortified beverages growing rapidly.

BY APPLICATION

Human Nutrition: This segment represents 48% of total consumption, translating to nearly 192 kilotons annually. Fortified food and beverage products—ranging from breakfast cereals to functional drinks—account for 78% of this segment’s demand, driven by widespread vitamin B3 deficiency prevention programs.

Human Nutrition is valued at USD 907.71 million in 2025, holding 48.6% share, and is projected to reach USD 1,233.29 million by 2034 at a CAGR of 3.46%.

Top 5 Major Dominant Countries in the Human Nutrition Application

• United States: USD 289.82 million in 2025, 31.9% share, reaching USD 393.59 million by 2034 at a CAGR of 3.47%, driven by dietary supplements.
• China: USD 249.20 million in 2025, 27.5% share, projected to hit USD 338.55 million by 2034 at a CAGR of 3.45%, with fortified foods growth.
• Germany: USD 102.66 million in 2025, 11.3% share, reaching USD 139.41 million by 2034 at a CAGR of 3.46%, led by cereal fortification.
• India: USD 93.39 million in 2025, 10.3% share, projected to hit USD 126.80 million by 2034 at a CAGR of 3.45%, supported by government health programs.
• Japan: USD 77.64 million in 2025, 8.5% share, expected to reach USD 105.05 million by 2034 at a CAGR of 3.46%, with functional food adoption.

Pharmaceuticals: At 32% market share, equivalent to 128 kilotons annually, this segment includes cardiovascular medications, lipid-modifying agents, and metabolic disorder treatments. Over 530 registered drug formulations globally contain niacin or niacinamide as an active ingredient.

The Pharmaceuticals segment is valued at USD 467.20 million in 2025, accounting for 25.0% share, and is projected to reach USD 634.18 million by 2034 at a CAGR of 3.47%, led by cardiovascular and metabolic disorder treatments.

Top 5 Major Dominant Countries in the Pharmaceuticals Application

• United States: USD 144.94 million in 2025, 31.0% share, expected to reach USD 196.54 million by 2034 at a CAGR of 3.48%, driven by niacin-based cholesterol-lowering drugs and supplement prescriptions.
• China: USD 103.62 million in 2025, 22.2% share, projected to hit USD 140.46 million by 2034 at a CAGR of 3.47%, fueled by expanding pharmaceutical manufacturing capacity.
• Japan: USD 79.42 million in 2025, 17.0% share, forecasted to reach USD 107.67 million by 2034 at a CAGR of 3.48%, with strong R&D in metabolic disorder therapies.
• Germany: USD 75.88 million in 2025, 16.2% share, expected to reach USD 102.91 million by 2034 at a CAGR of 3.47%, supported by strict healthcare quality standards.
• India: USD 63.34 million in 2025, 13.6% share, projected to reach USD 85.60 million by 2034 at a CAGR of 3.48%, boosted by generic niacin formulations.

Animal Nutrition: Comprising 14% of the market, around 56 kilotons yearly, animal nutrition use is concentrated in poultry (55% share) and swine feed (33% share), enhancing growth rates and feed efficiency in commercial farming.

The Animal Nutrition segment is worth USD 373.76 million in 2025, holding a 20.0% share, and is projected to reach USD 507.88 million by 2034 at a CAGR of 3.47%, driven by poultry, swine, and aquaculture feed fortification.

Top 5 Major Dominant Countries in the Animal Nutrition Application

• China: USD 126.06 million in 2025, 33.7% share, projected to reach USD 171.21 million by 2034 at a CAGR of 3.47%, supported by large-scale livestock and poultry farming.
• United States: USD 87.29 million in 2025, 23.3% share, expected to hit USD 118.58 million by 2034 at a CAGR of 3.48%, driven by commercial livestock feed production.
• Brazil: USD 66.71 million in 2025, 17.8% share, projected to reach USD 90.58 million by 2034 at a CAGR of 3.47%, supported by beef and poultry exports.
• India: USD 52.33 million in 2025, 14.0% share, expected to reach USD 71.04 million by 2034 at a CAGR of 3.48%, driven by poultry sector expansion.
• Germany: USD 41.37 million in 2025, 11.1% share, projected to reach USD 56.47 million by 2034 at a CAGR of 3.47%, supported by livestock health programs.

Cosmeceuticals: With 5% share, about 20 kilotons annually, this segment benefits from niacinamide’s role in improving skin elasticity, reducing wrinkles, and enhancing barrier function. Over 67% of anti-aging creams launched in 2023 contained niacinamide.

The Cosmeceuticals segment is valued at USD 186.88 million in 2025, representing 10.0% share, and is projected to reach USD 253.94 million by 2034 at a CAGR of 3.47%, driven by skin brightening and anti-aging products.

Top 5 Major Dominant Countries in the Cosmeceuticals Application

• United States: USD 61.67 million in 2025, 33.0% share, projected to reach USD 83.75 million by 2034 at a CAGR of 3.48%, led by premium skincare product consumption.
• China: USD 48.59 million in 2025, 26.0% share, expected to hit USD 65.91 million by 2034 at a CAGR of 3.47%, supported by strong personal care market growth.
• Japan: USD 29.90 million in 2025, 16.0% share, forecasted to reach USD 40.54 million by 2034 at a CAGR of 3.48%, driven by aging demographics and advanced cosmetic R&D.
• South Korea: USD 27.13 million in 2025, 14.5% share, projected to reach USD 36.77 million by 2034 at a CAGR of 3.48%, with strong exports of niacinamide-based K-beauty products.
• Germany: USD 19.58 million in 2025, 10.5% share, expected to reach USD 26.97 million by 2034 at a CAGR of 3.47%, backed by organic skincare demand.

Others: Niche uses make up 1% of demand, including industrial catalysts, specialty chemical intermediates, and research-grade reagents, totaling about 4 kilotons annually.

The Others segment is valued at USD 86.02 million in 2025, holding 4.6% share, and is projected to reach USD 117.65 million by 2034 at a CAGR of 3.47%, including industrial and specialty chemical uses.

Top 5 Major Dominant Countries in the Others Application

• United States: USD 27.53 million in 2025, 32.0% share, projected to hit USD 37.65 million by 2034 at a CAGR of 3.48%, led by specialty chemical applications.
• China: USD 21.50 million in 2025, 25.0% share, expected to reach USD 29.39 million by 2034 at a CAGR of 3.47%, driven by expanding manufacturing sectors.
• Germany: USD 13.76 million in 2025, 16.0% share, forecasted to reach USD 18.80 million by 2034 at a CAGR of 3.48%, supported by chemical industry innovation.
• India: USD 12.04 million in 2025, 14.0% share, projected to reach USD 16.44 million by 2034 at a CAGR of 3.47%, driven by domestic industrial applications.
• Japan: USD 11.19 million in 2025, 13.0% share, expected to reach USD 15.37 million by 2034 at a CAGR of 3.48%, backed by high-end specialty manufacturing.

Niacin and Niacinamide Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America holds a 26% global share, translating to approximately 104 kilotons of annual consumption. The region’s demand is led by the United States, where over 45% of niacinamide usage is tied to pharmaceutical production, followed by fortified foods and dietary supplements. Canada shows strong adoption in fortified staple foods and ready-to-drink nutrition beverages, while Mexico’s growth is tied to expanding poultry feed fortification.

North America is valued at USD 561.67 million in 2025, accounting for 30.0% share, and is projected to reach USD 763.39 million by 2034 at a CAGR of 3.48%, supported by high nutraceutical and pharmaceutical consumption.

North America - Major Dominant Countries in the Niacin and Niacinamide Market

• United States: USD 392.85 million in 2025, 70.0% share, projected to hit USD 534.37 million by 2034 at a CAGR of 3.49%, driven by supplement and fortified food demand.
• Canada: USD 83.59 million in 2025, 14.9% share, expected to reach USD 113.62 million by 2034 at a CAGR of 3.47%, supported by pharmaceutical exports.
• Mexico: USD 56.16 million in 2025, 10.0% share, projected to hit USD 76.19 million by 2034 at a CAGR of 3.48%, with growing animal feed sector.
• Cuba: USD 16.85 million in 2025, 3.0% share, forecasted to reach USD 22.85 million by 2034 at a CAGR of 3.47%, driven by health supplement imports.
• Dominican Republic: USD 12.22 million in 2025, 2.1% share, expected to hit USD 16.36 million by 2034 at a CAGR of 3.48%, with expanding personal care market.

Europe

Europe accounts for 23% of the global market, equivalent to around 92 kilotons annually. Germany leads with extensive usage in cosmeceuticals, contributing 28% of the region’s demand, while France and the UK show strong consumption in fortified cereals and clinical nutrition. Eastern Europe is experiencing accelerated adoption in animal feed fortification, particularly in Russia and Poland, driven by livestock productivity programs.

Europe is valued at USD 523.26 million in 2025, representing 28.0% share, and is projected to reach USD 711.03 million by 2034 at a CAGR of 3.47%, driven by food fortification regulations and cosmeceutical innovation.

Europe - Major Dominant Countries in the Niacin and Niacinamide Market

• Germany: USD 131.50 million in 2025, 25.1% share, projected to hit USD 178.63 million by 2034 at a CAGR of 3.48%, with strong healthcare manufacturing.
• France: USD 92.42 million in 2025, 17.7% share, expected to reach USD 125.51 million by 2034 at a CAGR of 3.47%, supported by fortified dairy and bakery products.
• United Kingdom: USD 86.85 million in 2025, 16.6% share, projected to reach USD 118.02 million by 2034 at a CAGR of 3.48%, led by cosmeceutical demand.
• Italy: USD 77.02 million in 2025, 14.7% share, expected to hit USD 104.55 million by 2034 at a CAGR of 3.47%, supported by supplement exports.
• Spain: USD 66.47 million in 2025, 12.7% share, forecasted to reach USD 90.32 million by 2034 at a CAGR of 3.48%, driven by health-conscious consumer trends.

Asia-Pacific

Asia-Pacific dominates with a 38% share, amounting to roughly 152 kilotons annually. China is both the largest producer and consumer, with over 50% of production used domestically in fortified food programs and cosmetics. India is emerging as a major hub for pharmaceutical-grade niacin production, with over 35 kilotons exported annually.

Asia is valued at USD 636.86 million in 2025, holding 34.1% share, and is projected to reach USD 865.78 million by 2034 at a CAGR of 3.47%, led by high dietary and animal feed consumption.

Asia - Major Dominant Countries in the Niacin and Niacinamide Market

• China: USD 286.05 million in 2025, 44.9% share, projected to hit USD 388.92 million by 2034 at a CAGR of 3.47%, backed by industrial and nutritional applications.
• India: USD 117.38 million in 2025, 18.4% share, expected to reach USD 159.42 million by 2034 at a CAGR of 3.48%, driven by livestock feed and supplement markets.
• Japan: USD 99.13 million in 2025, 15.6% share, projected to reach USD 134.68 million by 2034 at a CAGR of 3.47%, with advanced cosmeceuticals and pharma production.
• South Korea: USD 74.05 million in 2025, 11.6% share, forecasted to reach USD 100.50 million by 2034 at a CAGR of 3.48%, led by beauty and wellness sectors.
• Indonesia: USD 60.25 million in 2025, 9.5% share, expected to hit USD 81.46 million by 2034 at a CAGR of 3.47%, supported by fortified staple foods.

Middle East & Africa

The Middle East & Africa region holds a 13% market share, translating to about 52 kilotons annually. GCC countries, particularly Saudi Arabia and the UAE, show strong demand for imported niacinamide in fortified wheat flour and skincare products. In Africa, South Africa and Nigeria lead consumption, with over 60% of regional usage linked to vitamin-fortified staples aimed at addressing micronutrient deficiencies.

Middle East and Africa is valued at USD 146.99 million in 2025, holding 7.9% share, and is projected to reach USD 198.19 million by 2034 at a CAGR of 3.47%, with rising health awareness and fortified food consumption.

Middle East and Africa - Major Dominant Countries in the Niacin and Niacinamide Market

• Saudi Arabia: USD 37.82 million in 2025, 25.7% share, projected to hit USD 51.26 million by 2034 at a CAGR of 3.48%, driven by fortified dairy and grain consumption.
• South Africa: USD 30.35 million in 2025, 20.6% share, expected to reach USD 41.12 million by 2034 at a CAGR of 3.47%, with growing pharmaceutical imports.
• UAE: USD 26.46 million in 2025, 18.0% share, projected to hit USD 35.85 million by 2034 at a CAGR of 3.48%, supported by premium personal care demand.
• Egypt: USD 25.33 million in 2025, 17.2% share, expected to reach USD 34.31 million by 2034 at a CAGR of 3.47%, driven by animal nutrition applications.
• Nigeria: USD 27.03 million in 2025, 18.4% share, forecasted to hit USD 35.65 million by 2034 at a CAGR of 3.48%, supported by fortified grain programs.

List of Top Niacin and Niacinamide Companies

• Foodchem
• Vanetta
• Jubilant Life Sciences
• Vertellus Specialties
• Lasons India
• Zhejiang Lanbo Biotechnology
• Bactolac
• Lonza
• Koninklijke
• Fagron
• Merck
• Evonik
• DSM
• Brother Enterprises
• BASF

Top Two Companies With Highest Share

• DSM – Over 18% global production capacity.
• Jubilant Life Sciences – Holds 12% of worldwide output.

Investment Analysis and Opportunities

Global investment in Niacin and Niacinamide manufacturing capacity exceeded USD 500 million between 2022 and 2024, with over 27% allocated to bio-based production lines. Asia-Pacific leads capacity expansions, accounting for 55% of total investment. Strategic acquisitions in the nutraceutical manufacturing space are increasing supply chain integration, with 18% of top producers acquiring downstream supplement brands. Growing demand for preventive healthcare in emerging economies creates a 35-kiloton annual opportunity for producers entering fortified staple food markets.

New Product Development

Recent innovations in Niacin and Niacinamide formulations focus on high-bioavailability formats and environmentally sustainable production. Over 20% of new product launches in 2023 featured encapsulated niacinamide for controlled nutrient release. In cosmeceuticals, formulations targeting hyperpigmentation have doubled in product launches year-over-year. The pharmaceutical sector is adopting extended-release niacin tablets to improve patient compliance, while beverage manufacturers have launched over 120 fortified drink SKUs featuring niacinamide in Asia and North America.

Five Recent Developments

• DSM completed a new bio-based niacinamide plant in China with 15-kiloton capacity.
• Jubilant Life Sciences expanded production in India by 10 kilotons annually.
• BASF launched a high-purity niacinamide for dermatological applications in 2023.
• Evonik introduced an eco-certified production process reducing waste output by 25%.
• Lonza partnered with a major nutraceutical brand to supply encapsulated niacin for fortified beverages.

Report Coverage of Niacin and Niacinamide Market

This report covers global and regional market performance, segment-level analysis by type and application, and competitive landscape profiling of major manufacturers. It includes historical production and consumption data, supply chain analysis, and capacity expansion tracking. The scope extends to investment trends, regulatory frameworks, and emerging application areas such as functional beverages, clinical nutrition, and anti-aging skincare. Market insights are based on primary production data, verified consumption volumes, and industry-led innovation statistics, ensuring actionable intelligence for B2B stakeholders.

Niacin and Niacinamide Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1933.65 Million in 2026
Market Size Value By	USD 2627.51 Million by 2035
Growth Rate	CAGR of 3.47% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Powder Niacin and Niacinamide Granular Niacin and Niacinamide Liquid Niacin and Niacinamide By Application : Human Nutrition Pharmaceuticals Animal Nutrition Cosmeceuticals Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample